[弥漫性甲状腺增生所致甲状腺功能亢进患者服用三碘甲状腺原氨酸后碘摄取、PBI-131、PBI-127及临床症状的演变。淋巴系统和长效甲状腺刺激素在格雷夫斯病刺激作用中的作用] - Suppr | 超能文献

[Evolution of iodine uptake, PBI-131, PBI-127 and clinical symptoms following administration of triiodothyronine to subjects with hyperthyroidism caused by diffuse thyroid hyperplasia. Role of the lymphatic system and LATS in the effect of Graves disease stimulation].

作者信息

Mahaux J E, Chamla-Soumenkof J, Nagel M, Levin S

出版信息

Ann Endocrinol (Paris). 1968 Jul-Aug;29(4):483-95.

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

[Evolution of iodine uptake, PBI-131, PBI-127 and clinical symptoms following administration of triiodothyronine to subjects with hyperthyroidism caused by diffuse thyroid hyperplasia. Role of the lymphatic system and LATS in the effect of Graves disease stimulation].[弥漫性甲状腺增生所致甲状腺功能亢进患者服用三碘甲状腺原氨酸后碘摄取、PBI-131、PBI-127及临床症状的演变。淋巴系统和长效甲状腺刺激素在格雷夫斯病刺激作用中的作用]

Ann Endocrinol (Paris). 1968 Jul-Aug;29(4):483-95.

2

[Action of 1-triiodothyronine on protein-bound iodine in the blood (PBI 127) of patients suffering from hyperthyroidism with diffuse thyroid hyperplasia].

Ann Endocrinol (Paris). 1967 Mar-Apr;28(2):214-9.

3

Suppressibility of thyroid function during treatment with antithyroid drugs in Grave's disease.格雷夫斯病患者使用抗甲状腺药物治疗期间甲状腺功能的可抑制性。

J Clin Endocrinol Metab. 1970 Mar;30(3):406-7. doi: 10.1210/jcem-30-3-406.

4

Thyroid gland in Graves' disease: victim or culprit?格雷夫斯病中的甲状腺：受害者还是罪魁祸首？

Metabolism. 1970 Oct;19(10):760-72. doi: 10.1016/0026-0495(70)90074-0.

5

Factors influencing the relationship between labelled triiodothyronine and thyroxine levels in the serum of patients with Graves' disease.

Endokrinologie. 1973 Jan;61(1):52-64.

6

Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.甲状腺毒症中长效甲状腺刺激物保护剂水平与甲状腺 131-I 摄取率的相关性

Br Med J. 1974 Apr 27;2(5912):199-201. doi: 10.1136/bmj.2.5912.199.

7

The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).长效甲状腺刺激素（LATS）水平高的格雷夫斯病患者甲状腺放射性消融的效果。

Am J Med. 1969 Feb;46(2):217-26. doi: 10.1016/0002-9343(69)90006-0.

8

Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.甲状腺功能亢进治疗期间血清长效甲状腺刺激素含量与甲状腺抑制性的分离

J Clin Endocrinol Metab. 1970 Apr;30(4):524-8. doi: 10.1210/jcem-30-4-524.

9

[Biological investigation in hyperthyroidism].[甲状腺功能亢进症的生物学研究]

Cah Med. 1972 Dec 30;13(17):1235-42.

10

Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.关于长效甲状腺刺激素与格雷夫斯病中眼病变之间因果关系的观察。

J Clin Endocrinol Metab. 1968 Aug;28(8):1177-82. doi: 10.1210/jcem-28-8-1177.